| 000 | 01600 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250517163844.0 | ||
| 264 | 0 | _c20181026 | |
| 008 | 201810s 0 0 eng d | ||
| 022 | _a2194-7236 | ||
| 024 | 7 |
_a10.1007/s00240-017-0998-6 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMilliner, Dawn | |
| 245 | 0 | 0 |
_aA randomised Phase II/III study to evaluate the efficacy and safety of orally administered Oxalobacter formigenes to treat primary hyperoxaluria. _h[electronic resource] |
| 260 |
_bUrolithiasis _cAug 2018 |
||
| 300 |
_a313-323 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial, Phase II; Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aBiological Therapy _xadverse effects |
| 650 | 0 | 4 |
_aCalcium Oxalate _xblood |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aChild, Preschool |
| 650 | 0 | 4 |
_aCreatinine _xblood |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGlomerular Filtration Rate |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHyperoxaluria, Primary _xblood |
| 650 | 0 | 4 |
_aKidney Calculi _xblood |
| 650 | 0 | 4 | _aKidney Function Tests |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aOxalobacter formigenes _xmetabolism |
| 650 | 0 | 4 |
_aPlacebos _xadministration & dosage |
| 650 | 0 | 4 | _aRenal Elimination |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aHoppe, Bernd | |
| 700 | 1 | _aGroothoff, Jaap | |
| 773 | 0 |
_tUrolithiasis _gvol. 46 _gno. 4 _gp. 313-323 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s00240-017-0998-6 _zAvailable from publisher's website |
| 999 |
_c27377884 _d27377884 |
||